AI Article Synopsis
- Clinical reminders can help doctors follow clinical guidelines, but they can also lead to issues like alert fatigue and increased workload, making them easier to ignore.
- A study analyzed data from over 87,000 patient visits and found that while physicians generally included most eligible patients for cardiovascular disease prevention (85.7%), they often skipped these suggestions (62.6%).
- Factors like existing health conditions made it more likely for patients to be included in the intervention, while older patients were less likely to be enrolled.
Article Abstract
Clinical reminders can promote adherence with evidence-based clinical guidelines, but they may also have unintended consequences such as alert fatigue, false alarms and increased workload, which cause clinicians to ignore them. The described clinical reminder system identifies patients eligible for primary prevention of cardiovascular diseases and lets the physician to choose which patients will be included in the reminders intervention. We analyzed data of 87,165 visits of 35,699 patients and evaluated factors which may affect clinicians' decision to enroll patients to the intervention. The physicians included most of the patients suggested for inclusion (85.7%). Yet, they skipped the enrollment suggestion in 62.6% of the visits. Patients with a cardiovascular disease, dyslipidemia, diabetes, or hypertension were more likely to be included in the intervention, while older patients were less likely to be included. Insights regarding the usability of clinical reminders are discussed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Alternative healthcare delivery arrangements in Nepal: a systematic review of comparative effectiveness, safety and cost-effectiveness studies.
BMJ Glob Health
January 2025
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
Background: The way that healthcare services are organised and delivered (termed 'healthcare delivery arrangements') is a key aspect of a health system. Changing the way health care is delivered, for example, task shifting that delivers the same care at lower cost, may be one way of improving healthcare system sustainability. We synthesised the existing randomised trial evidence to compare the effects of alternative healthcare delivery arrangements versus usual care in Nepal.
View Article and Find Full Text PDFBackground: Practice effects are a well-known cognitive phenomenon that is reduced in patients with Alzheimer's disease (AD). We aimed to investigate whether cognitively unimpaired (CU) individuals within the Alzheimer's continuum (i.e.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Background: Objective Subtle Cognitive Decline (obj-SCD) can be identified through standardized neuropsychological tests and may precede the development of Mild Cognitive Impairment (MCI). Nevertheless, current clinical and research criteria lack a standardized protocol for identifying obj-SCD. This study introduces cutting-edge sensitive methods to characterize obj-SCD, defined through Alzheimer's disease (AD) biomarker-based longitudinal cognitive performance in episodic memory.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Università di Modena e Reggio Emilia, Modena, Italy.
Background: The effect of amyloid-b brain deposition on cognition is still debated, since it has been shown that its accumulation begins almost 15 years before cognitive symptoms' onset, then reaches a plateau while cognition continues to decline. We studied if there is a parallel between amyloid-b deposition and cognitive performances in young-onset Mild Cognitive Impairment (MCI) patients, and if it is associated to symptoms' duration.
Method: Subjects with a diagnosis of MCI and symptoms' onset ≤ 65 years underwent neuropsychological assessment, Magnetic Resonance Imaging, and (F)Flutemetamol-PET (amy-PET).
Clinical Manifestations.
Alzheimers Dement
December 2024
Brigham and Women's Hospital, Boston, MA, USA.
Background: The impact of knowledge of β-amyloid status on cognitively unimpaired persons' cognitive test performance is unknown.
Method: Cognitively unimpaired adults aged 65-80 with a first-degree relative with AD received a dementia risk estimate and were randomly assigned to disclosure (D+) or non-disclosure (D-) of their β-amyloid PET scan result. At 6 weeks and 6 months post-disclosure, participants completed the ADCS-PACC, a composite of Free and Cued Selective Reminding (free portion), Logical Memory IIa test, Digit-Symbol Substitution, and MMSE.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!